Clinical Trial Update: Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2% [Phase 3]

View source ↗

Summary

Phase 3 study comparing the fixed-dose combination brinzolamide 1%/brimonidine 0.2% to each component alone in open-angle glaucoma and ocular hypertension, asse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Brimonidine (brimonidine)
• Brinzolamide (Brinzolamide)
• Simbrinza (brinzolamide/brimonidine)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-07-04